PODESTA GROUP, INC. for EISAI INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Medicare/Medicaid MMM
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Education EDU
Student Loan Auction Rate Securities (SLARS).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ELIZABETH ANN MORRA New | News Dir./Co-Anchor/Prod'r, S. Repub. Conf. |
Pharmacy PHA
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities (SLARS).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ELIZABETH ANN MORRA New | News Dir./Co-Anchor/Prod'r, S. Repub. Conf. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.